NL-OMON20175招募中不适用
Off-label use of Risperidone in Children and Adolescents (ORCA): a double-blind placebo-controlled discontinuation trial
niversity Medical Center Groningen (UMCG)0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •- Be between the ages of six and seventeen years and eight months
排除标准
- •- Risperidone was discontinued for ≥ two months in the last year.
- •- Current psychosis.
研究者
相似试验
已完成
4 期
Off-label use of Risperidone in Children and Adolescents (ORCA): a double-blind placebo-controlled discontinuation trial10037173long-term off-label risperidone treatmentNo specific conditionNL-OMON44901niversitair Medisch Centrum Groningen120
进行中（未招募）
不适用
Off-label risperidone in children and adolescents (ORCA): Discontinuation studyEUCTR2014-003651-54-NLMCG
进行中（未招募）
不适用
A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic DisorderEUCTR2015-001220-31-Outside-EU/EEAJohnson & Johnson Pharmaceutical Research and Development, L.L.C.96
Unknown
不适用
Pharmacological Treatment of Children and Adolescents With Severe Mood DysregulationSevere Mood DysregulationNCT00825552Federal University of Rio Grande do Sul20
已完成
4 期
A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic DisorderAutistic DisorderAutismNCT00576732Johnson & Johnson Pharmaceutical Research & Development, L.L.C.96